Manifestations and management of ocular toxoplasmosis.
D000305:Adrenal Cortex Hormones / Q000009:adverse effects; D000818:Animals; D002825:Chorioretinitis / Q000188:drug therapy / Q000209:etiology*; D002981:Clindamycin / Q000627:therapeutic use; D006801:Humans; D011739:Pyrimethamine / Q000627:therapeutic use; D011817:Rabbits; D013449:Sulfonamides / Q000627:therapeutic use; D014122:Toxoplasma / Q000254:growth & development; D014126:Toxoplasmosis, Ocular / Q000175:diagnosis / Q000188:drug therapy*
D000305:Adrenal Cortex Hormones; D013449:Sulfonamides; D002981:Clindamycin; D011739:Pyrimethamine